| Business Summary | | DiaSys
Corporation
designs,
develops,
manufactures
and
distributes
instruments
which
standardize
and
automate
routine,
labor
intensive
procedures
in
hospital,
clinical
and
private
physician
laboratories.
The
Company
develops
products
that
increase
accuracy
of
and
reduce
the
costs
to
analyze
human
body
fluids.
Since
inception,
the
Company
has
developed
and
patented
several
new
proprietary
technologies;
erected
the
infrastructure
needed
to
support
global
manufacturing
and
distribution
operations;
established
market
and
technical
acceptance
of
its
initial
products
among
the
medical
laboratory
community;
attracted
significant
strategic
selling
partners
in
major
markets;
and
implemented
a
plan
for
long
term
market
penetration.
The
Company
markets
its
products
in
North
America,
Europe,
Central
America,
China
and
Asia-Pacific. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | DiaSys
Corporation
is
a
devevelopment
stage
company
engaged
in
the
design,
development,
manufacture
and
distribution
of
proprietary
products
for
medical
and
clinical
laboratory
applications.
For
the
nine
months
ended
3/31/01,
revenues
increased
83%
to
$1.4m.
Net
loss
increased
56%
to
$906
thousand.
Revenues
reflect
continued
implementation
of
the
Company's
growth
plan.
Higher
loss
suffered
from
increased
sales
related
commissions
and
bonuses. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Todd DeMatteo, 43 Pres,
CEO, Director | $233K | Marshall Smith, 29 CFO,
VP of Fin. and Admin., Assistant Sec. | -- | Conrad Shelnut, 65 Sec.,
Director | -- | Dollar amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|